Oral Leukoplakia

Oral Leukoplakia - White Patch Basics

• Clinically white patch/plaque; cannot be scraped off.
• WHO: Not characterized as any other definable lesion.
• Most common oral potentially malignant disorder (OPMD).
• Etiology: Tobacco (smoking/smokeless) primary; alcohol, HPV.
• Types: Homogenous (uniform, lower risk), Non-homogenous (speckled, nodular, verrucous - higher malignant potential).

⭐ Non-homogenous leukoplakia has a significantly higher risk of malignant transformation (4-7 times greater than homogenous).

Leukoplakia Risks - Culprits & Causes

• Tobacco: Key etiological factor (smoking, smokeless forms like gutka, khaini). Dose & duration dependent.
• Alcohol: Synergistic with tobacco, ↑ risk significantly.
• Chronic Irritation: Dental factors (e.g., sharp cusps, rough restorations, ill-fitting dentures).
• Infections:
  • Candida albicans (especially in non-homogenous/speckled types).
  • HPV (Human Papillomavirus, notably types 16, 18).
• Nutritional Deficiencies: Vitamins A, B complex.
• Idiopathic: No known cause in ~20% of cases.

⭐ Proliferative verrucous leukoplakia (PVL) has a very high malignant transformation rate, often >70%.

Leukoplakia Looks - Spotting the Signs

• Clinical Sign: Persistent, adherent white patch/plaque; cannot be scraped off.
• Types & Malignant Potential:
  • Homogeneous: Uniform, flat, thin; may be smooth/wrinkled. Lower risk.
  • Non-homogeneous (Higher risk):
    • Speckled (Erythroleukoplakia): Mixed red & white.
    • Nodular: Small, raised granules/nodules.
    • Verrucous: Warty, exophytic projections.
• High-Risk Sites:
  • Floor of mouth
  • Ventrolateral tongue
  • Soft palate complex
  • Lip vermilion

⭐ Erythroleukoplakia (speckled non-homogeneous type) has the highest malignant transformation rate.

Leukoplakia Diagnosis - Biopsy Unveiled

• Mandatory Biopsy: Confirms diagnosis; crucial for assessing dysplasia.
• Key Differentials: Lichen planus, candidiasis, frictional keratosis, squamous cell carcinoma (SCC).
• Histopathology:
  • Hyperkeratosis (ortho- or parakeratosis), acanthosis.
  • Epithelial Dysplasia Grading (WHO criteria):
    • Mild: Changes in basal 1/3 of epithelium.
    • Moderate: Changes extend to middle 1/3 (basal 2/3).
    • Severe: Changes extend to superficial 1/3 (>2/3).
    • Carcinoma in situ (CIS): Full-thickness atypia, intact basement membrane.

⭐ Non-homogeneous leukoplakia (e.g., speckled, nodular, verrucous) has a significantly higher malignant transformation risk (4-7 times) compared to homogeneous leukoplakia. This is a critical prognostic indicator for NEET PG.

Leukoplakia's Danger - Cancer Connection

• Most common oral premalignant lesion; risk of SCC.
• Malignant transformation rate: 1-20%; overall ~4%.
• Factors ↑ risk of malignant change:
  • Lesion persistence (e.g., > 10 years).
  • Female gender, non-smoker status.
  • High-risk sites: floor of mouth, ventrolateral tongue, soft palate.
  • Non-homogeneous appearance (speckled, nodular, verrucous).
  • Presence and severity of epithelial dysplasia on biopsy.

⭐ Epithelial dysplasia is the single most important predictor of malignant transformation.

Managing Leukoplakia - Treatment Paths

• Aim: Manage dysplasia, reduce malignant transformation risk.
• Initial:
  • Cease risk factors (tobacco, alcohol).
  • Mandatory biopsy for grading.
• Treatment:
  • No/Mild Dysplasia: Observe, control risks, review regularly.
  • Mod/Severe Dysplasia: Surgical excision (scalpel, laser), cryotherapy.
• Follow-up: Lifelong surveillance critical.

⭐ High recurrence (up to 35%) post-treatment mandates vigilant, long-term follow-up for recurrence or malignant change.

High-Yield Points - ⚡ Biggest Takeaways

• Oral leukoplakia: white patch/plaque on oral mucosa, cannot be scraped off, not otherwise classifiable.
• It's a premalignant lesion; risk of transformation to squamous cell carcinoma (SCC).
• Tobacco use (smoking/smokeless) is the primary etiological factor.
• Non-homogeneous types (speckled, nodular) carry ↑ malignant risk than homogeneous type.
• Biopsy is mandatory for diagnosis and to assess for dysplasia or carcinoma.
• Management: stop risk factors (tobacco, alcohol), long-term follow-up; excision for dysplastic lesions.